Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Anja Ostrbenk Vanlencak"'
Autor:
Karen Canfell, Maribel Almonte, E. Peeters, Chris J.L.M. Meijer, Jesper Bonde, Kate Cuschieri, Peter Hillemanns, Marc Arbyn, Nicolas Wentzensen, Joakim Dillner, Marie Simon, Anja Ostrbenk Vanlencak, Remila Rezhake, Fang-Hui Zhao, Johannes Berkhof, Mario Poljak, Silvia de Sanjosé, Lan Xu, Murat Gultekin
Publikováno v:
Arbyn, M, Simon, M, Peeters, E, Xu, L, Meijer, C J L M, Berkhof, J, Cuschieri, K, Bonde, J, Ostrbenk Vanlencak, A, Zhao, F-H, Rezhake, R, Gultekin, M, Dillner, J, de Sanjosé, S, Canfell, K, Hillemanns, P, Almonte, M, Wentzensen, N & Poljak, M 2021, ' 2020 list of human papillomavirus assays suitable for primary cervical cancer screening ', Clinical Microbiology and Infection, vol. 27, no. 8, pp. 1083-1095 . https://doi.org/10.1016/j.cmi.2021.04.031
CLINICAL MICROBIOLOGY AND INFECTION
Clinical Microbiology and Infection
CLINICAL MICROBIOLOGY AND INFECTION
Clinical Microbiology and Infection
Background Only clinically validated HPV assays can be accepted in cervical cancer screening. Objectives To update the list of high-risk HPV assays that fulfil the 2009 international validation criteria (Meijer-2009). Data Sources PubMed/Medline, Emb